GlassScriptPhysician profile
Katherine Parkinson
NPI 1518997162
$285.69
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $61.74 | 2019 | |
| Celgene Corporation | $43.29 | 2019 | |
| Amgen INC. | $37.48 | 2019 | |
| Sun Pharmaceutical Industries INC. | $34.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.17 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.76 | 2019 | |
| Dusa Pharmaceuticals, INC. | $13.14 | 2019 | |
| Abbvie INC. | $12.99 | 2019 | |
| Janssen Biotech, INC. | $12.60 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $10.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Parkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.